{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:32:37Z","timestamp":1757309557402},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"coronary microvascular innovation foundation of china","award":["2018-CCA-CMVD-01"],"award-info":[{"award-number":["2018-CCA-CMVD-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Coronary microvascular dysfunction (CMVD), highly prevalent among patients with a mental disorder (anxiety or depression), is closely related to adverse cardiac events, including hospitalization, sudden cardiac death, and myocardial infarction. Shexiang Tongxin Dropping Pills (STDP), a traditional Chinese medicine, exerts endothelial protective function by anti-inflammation, anti-oxidative stress, and promoting blood circulation. STDP protects against CMVD in previous fundamental studies. The present trial is aiming at evaluating the effect of STDP on CMVD among depressed or anxious patients with non-obstructive coronary artery disease (NOCAD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and analysis:<\/jats:title>\n            <jats:p>Seventy-two depressed or anxious patients diagnosed with NOCAD combined with CMVD utilizing coronary artery angiography and stress cardiac magnetic resonance (CMR) will be recruited in the present study. These patients will be randomized into two groups, namely, Nicorandil group (Nicorandil combined with routine medicine), and STDP groups (STDP combined with routine medicine). The change of CMVD status by assessing absolute myocardial blood flow and myocardial reperfusion using stress CMR 3-month after discharge is defined as the primary endpoint. Major adverse cardiac events (MACEs), quality of life (QOL), and metal disorder improvement are defined as the secondary endpoints. Seattle angina questionnaire (SAQ) which is used to assess angina pectoris and QOL will be recorded at 1-, 3-, 6-, 9-, 12-month of follow-up. Seven-item Generalized Anxiety Disorder Scale (GAD-7) and 9-item depression module from the Patient Health Questionnaire (PHQ9) which utilized to evaluate anxiety and depression, respectively, will be recorded at 1-, 3-, 6-, 9-, 12-month of follow-up. This study will first evaluate the efficacy of STDP on CMVD among patients with a mental disorder and NOCAD, and discuss the potential mechanisms, providing therapeutic evidence for the STDP for these patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000020099","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T03:21:08Z","timestamp":1590636068000},"page":"e20099","source":"Crossref","is-referenced-by-count":3,"title":["The effect of Shexiang Tongxin Dropping Pills on coronary microvascular dysfunction (CMVD) among those with a mental disorder and non-obstructive coronary artery disease based on stress cardiac magnetic resonance images"],"prefix":"10.1097","volume":"99","author":[{"given":"Jinfan","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Zuo","sequence":"additional","affiliation":[{"name":"Department of Community Health Research, Beijing Anzhen Hospital, Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Yong","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiantao","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Cardiology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"R1-20240521","first-page":"643","article-title":"Frequency of negative coronary arteriographic findings in patients with chest pain is related to community practice patterns","volume":"8","author":"Farrehi","year":"2002","journal-title":"Am J Manag Care"},{"key":"R2-20240521","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jacc.2013.09.055","article-title":"Normal coronary rates for elective angiography in the Veterans Affairs Healthcare System: insights from the VA CART program (veterans affairs clinical assessment reporting and tracking)","volume":"63","author":"Bradley","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R3-20240521","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/CIRCULATIONAHA.113.008507","article-title":"Effects of sex on coronary microvascular dysfunction and cardiac outcomes","volume":"129","author":"Murthy","year":"2014","journal-title":"Circulation"},{"key":"R4-20240521","article-title":"Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines","author":"Vaccarino","year":"2019","journal-title":"Eur Heart J"},{"key":"R5-20240521","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10739680590896072","article-title":"Potassium channels in the peripheral microcirculation","volume":"12","author":"Jackson","year":"2005","journal-title":"Microcirculation"},{"key":"R6-20240521","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jacc.2017.11.071","article-title":"Gadolinium-free cardiac MR stress T1-mapping to distinguish epicardial from microvascular coronary disease","volume":"71","author":"Liu","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R7-20240521","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12968-018-0435-1","article-title":"Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease","volume":"20","author":"Zorach","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"R8-20240521","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jacc.2017.12.046","article-title":"Diagnosis of microvascular angina using cardiac magnetic resonance","volume":"71","author":"Liu","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R9-20240521","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4244\/EIJV9I9A178","article-title":"Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study","volume":"9","author":"Hirohata","year":"2014","journal-title":"EuroIntervention"},{"key":"R10-20240521","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.19082\/4934","article-title":"Effect of nicorandil on QT dispersion in patients with stable angina pectoris undergoing elective angioplasty: a triple-blind, randomized, placebo-controlled study","volume":"9","author":"Suleimani","year":"2017","journal-title":"Electron Physician"},{"key":"R11-20240521","doi-asserted-by":"crossref","first-page":"18597","DOI":"10.3390\/molecules201018597","article-title":"Qualitative and quantitative analysis of the major constituents in Shexiang Tongxin dropping Pill by HPLC-Q-TOF-MS\/MS and UPLC-QqQ-MS\/MS","volume":"20","author":"Chen","year":"2015","journal-title":"Molecules"},{"key":"R12-20240521","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.3892\/mmr.2017.6963","article-title":"Protective effects of Shexiang Tongxin Dropping Pill on pituitrin induced acute myocardial ischemia in rats","volume":"16","author":"Lin","year":"2017","journal-title":"Mol Med Rep"},{"key":"R13-20240521","doi-asserted-by":"crossref","first-page":"108958","DOI":"10.18632\/oncotarget.22440","article-title":"Shexiang Tongxin dropping pill protects against isoproterenol-induced myocardial ischemia in vivo and in vitro","volume":"8","author":"Qi","year":"2017","journal-title":"Oncotarget"},{"key":"R14-20240521","first-page":"102","article-title":"An effective analysis of treating angina pectoris of the Qixu Xueyu syndrome with Shexiang Tongxin Diwan","volume":"9","author":"Hua","year":"2017","journal-title":"Clin J Chin Med"},{"key":"R15-20240521","first-page":"281","article-title":"Meta-analysis of Musk Tongxin dripping pills in treatment of angina pectoris of coronary heart disease","volume":"39","author":"Wenhua","year":"2018","journal-title":"Med J NDFNC"},{"key":"R16-20240521","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jep.2014.11.013","article-title":"Shexiang Tongxin dropping pill attenuates atherosclerotic lesions in ApoE deficient mouse model","volume":"159","author":"Xiong","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"R17-20240521","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","article-title":"Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population","volume":"46","author":"L\u00f6we","year":"2008","journal-title":"Med Care"},{"key":"R18-20240521","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review","volume":"72","author":"Taqueti","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R19-20240521","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11655-018-2559-4","article-title":"Effect of Shexiang Tongxin Dropping Pills () on the immediate blood flow of patients with coronary slow flow","volume":"25","author":"Wang","year":"2019","journal-title":"Chin J Integr Med"},{"key":"R20-20240521","first-page":"2969","article-title":"Protective effects of Shexiang TongXin Dropping Pill on microcirculation dysfunction in myocardial infarction mice induced by LPS and its mechanism","volume":"15","author":"Zhang","year":"2017","journal-title":"Chin J Integr Med Cardio-cerebrovasc Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T20:03:03Z","timestamp":1716321783000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000020099"}},"subtitle":["A study protocol"],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":20,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000020099","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]}}}